Development of Novel Cathepsin V inhibitors to Validate role in Breast Cancer
School of Medicine, Dentistry and Biomedical Sciences
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
The CCRCB Drug Discovery lab is focused on the development of highly potent, selective and drug-like lead compounds for the treatment of human diseases.
Working for PIs in the University we have developed a number of small molecule protease inhibitor tool compounds, that are currently being utilized to validate their target proteins as bone-fide drug targets.
- Dr Richard Williams: School of Medicine, Dentistry and Biomedical Sciences
Contact info
- View Academic Profile
- askmhls@qub.ac.uk
- +44 (0)28 9097 2791
Research Interests
Open to PhD applications in the field of
Make a PhD enquiry
- MRes project: Development of Novel Cathepsin V inhibitors to Validate role in Breast Cancer
- MRes project: Testing of Epigenetic Probes in Cancer Immune Cells
- MRes project: Design, synthesis and SAR exploration of Novel LSD1 inhibitors
Public outreach & key achievements
- Member of CRUK Accelerator Network Program in Structural Biology
- Peer reviewer of Medicinal Chemistry Journals; Journal of Medicinal Chemistry, Bioorganic Medicinal Chemistry Letters and Journal of Pharmacy and Pharmacology
- School Outreach program with Regent House School, Newtownards
Discover More
- Faculty of Medicine, Health and Life Sciences
- School of Medicine, Dentistry and Biomedical Science
- The Patrick G Johnston Centre for Cancer Research